Zara Reyes: Megan, quick question before we start — do you think Robert Koch knew he was building a religion?
Megan Skiendel: Ha — I mean, 1882, he identifies the tuberculosis bacterium, the room probably felt like a revival meeting. Specific microbe, specific disease, God is orderly. So no, probably not. But that's kind of the problem.
Zara Reyes: That's exactly what we're getting into today — germ theory as a framework that won so completely it became load-bearing. And now the cracks are showing in a very specific way.
Megan Skiendel: Here's what got me: there's PNAS research making the case that who dies from an infection is determined by the host genome, not the microbe itself. Same pathogen, two people — one dies, one doesn't. Koch's postulates don't have a slot for that variable.
Zara Reyes: Wait — Koch's postulates require the microbe to reproduce the disease in every case. So if the host genome is the deciding factor, the whole postulate structure is—
Megan Skiendel: Already shaky from the start. But nobody was interrogating it because it was delivering results.
Zara Reyes: And the results masked the problem — which is now 70% of disease burden in developed countries. Chronic, noncommunicable conditions. Heart disease, cancer, autoimmune. Not a pathogen in sight.
Megan Skiendel: So the actual question sitting underneath all of this: if the same microbe doesn't reliably produce the same outcome — what exactly did germ theory prove? And frankly, why are we still building medicine on top of it?
Zara Reyes: But that's the part that breaks open — why did it win in the first place? Like, before Pasteur, before Koch, illness was just... weather. Broussais and the whole humoral tradition — internal imbalances, mysterious fluids, no villain. You couldn't point at anything.
Megan Skiendel: You couldn't arrest anyone.
Zara Reyes: Exactly — it's a murder mystery with no suspect. And then April 7, 1864, Pasteur stands up at the Sorbonne and says: no, there are tiny living things doing this. Fermentation, decay, disease — organisms, not bad air. Suddenly you have a suspect.
Megan Skiendel: And Koch hands you the handcuffs. 1876 — he isolates Bacillus anthracis, links it specifically to anthrax. One bacterium, one disease, reproducible in a lab. Then tuberculosis in 1882, cholera in 1883. The pattern locks in so fast it's almost violent.
Zara Reyes: Wait, that speed matters. Three diseases in seven years. That's not a theory anymore — that's a method you can hand to anyone.
Megan Skiendel: Koch's postulates are basically an exportable rulebook. Find the microbe in every case, isolate it, reproduce the disease. Frankly, any trained physician anywhere could run that protocol. Broussais's humoral framework couldn't offer you that — you were always interpreting, never testing.
Zara Reyes: So germ theory didn't win because it was more true. It won because it was the most solvable story medicine had ever been handed. The bug is the villain, the lab test is the arrest, the antibiotic is the sentence. That's — I mean, that's a complete narrative arc.
Megan Skiendel: And a fundable one. You can measure outcomes. That's not nothing — that's everything, institutionally.
Zara Reyes: Which is where it gets uncomfortable — because the framework that built medicine's entire credibility, the postulates, the 'one disease, one pathogen' logic — none of that has a slot for what's actually killing people now. And nobody replaced the story.
Megan Skiendel: And that's the thing about infrastructure — it doesn't announce itself. Vaccines, antibiotics, pasteurization. All of it drops directly out of the pathogen-first logic. You identify the microbe, you neutralize it, you measure the outcome. By mid-century that playbook had basically ended mass death from infectious disease in industrialized countries.
Zara Reyes: So the mandate was complete.
Megan Skiendel: Mid-1960s, experts are literally saying — infectious disease, largely controlled, time to shift focus. Heart disease, cancer, psychiatric disorders. That moment is actually documented. And what's wild is nobody noticed that the tool they were handing the next generation couldn't do the new job.
Zara Reyes: No but picture — okay, picture a rheumatology clinic, 2024. A woman hands her doctor a stack of symptoms. He gives her a drug that suppresses her immune system. And she asks, what's causing this? And he genuinely cannot name a pathogen. Cannot run a Koch's postulate chain. There's no anthrax moment, no Bacillus anthracis in a dish. He's just... managing a system that's attacking itself.
Megan Skiendel: In a hospital coded for something else entirely.
Zara Reyes: Exactly — the billing code, the insurance category, the research funding pipeline, all of it still flows through a framework built to hunt villains that aren't there. And the CDC and Preventing Chronic Disease have explicitly named this — they've called for a 'germ theory equivalent for chronic disease.' Like, the institution knows it's missing the organizing logic.
Megan Skiendel: And that call has been sitting out there unanswered. Frankly, that's the tell — when an institution publishes that it needs a new framework and then doesn't build one, the old framework isn't just incomplete. It's load-bearing in ways nobody wants to touch.
Zara Reyes: The success is the trap.
Megan Skiendel: Which — honestly, this gets darker when you look at what happens when researchers actually try to stretch the postulates toward chronic disease. Epstein-Barr virus, Paul Ewald's work on cryptic transmission — that's where the framework starts showing its real ceiling, and we'll get there.
Zara Reyes: But stretching is the wrong word for what Epstein-Barr does to Koch's postulates — it doesn't stretch them, it just... stands there while they fail. Hodgkin's disease patients, aggressive breast cancers — conditions nobody called infectious — and EBV is sitting in the tissue. That's not the postulates working at their limit. That's them not working at all.
Megan Skiendel: Because Koch's rulebook needs one microbe, one disease, reproducible every time. EBV doesn't do that.
Zara Reyes: Most people who carry EBV never get Hodgkin's. So the postulate — reproduce the disease in every exposed host — it's just structurally unmet.
Megan Skiendel: Which is exactly where Paul Ewald comes in — and honestly, his framing is the clearest I've seen. He's an evolutionary biologist, and his argument is that medicine's reluctance to look at infectious causes of chronic disease isn't just bias. It's logical. Cryptic transmission chains, multi-pathogen interactions — those literally don't fit the criteria Koch wrote. So researchers aren't ignoring the question out of laziness. The rulebook disqualifies it before the study gets funded.
Zara Reyes: Wait — so Koch's postulates aren't just failing to explain chronic disease, they're actively blocking the research that might?
Megan Skiendel: The criteria set the floor for what counts as evidence. If your transmission chain is cryptic — if the virus is dormant, if it needs a co-factor, if host genetics determine whether it activates — you can't meet the standard. So the funding doesn't move.
Zara Reyes: And that's where the PNAS finding lands hardest — like, if death from infection is rooted in the host genome and not the microbe, terrain theory isn't fringe anymore. Immunology, psychoneuroimmunology, microbiome research — that's actually the systems-biology correction terrain theory was always pointing at. But we can't say that cleanly because the postulates made 'host factors' sound like the anti-vax argument.
Megan Skiendel: And yet germ theory remains — the phrase is 'incontestably strong in medical terms.' Scientifically contested, institutionally indispensable. That's the paradox you can't resolve with a better paper.
Zara Reyes: So the actual hard question — if the framework is wrong at the edges but hospitals are staffed, insurance is coded, and funding flows through it... I mean, what does replacing it even look like? Not the science. The infrastructure.
Megan Skiendel: Look, the thing I keep not being able to put down — and I don't have a clean answer here — is that the same framing, 'the host matters more than the germ,' the terrain-theory core of it, got picked up during COVID as cover for rejecting vaccines entirely. Anti-vaccine movements ran that argument. And now genomics, microbiome sequencing, immune profiling — that research is actually giving terrain theory an empirical foundation it never had in the 19th century. So the science got more legitimate exactly when the politics made it radioactive.
Zara Reyes: Which makes the disentanglement harder, not easier. Like, you can't just say 'that's the fringe version' anymore — the fringe version is citing the same immunology journals.
Megan Skiendel: And medicine hasn't built the separation. That's the honest place this conversation ends up — germ theory gave everyone a story with a villain. One microbe, one disease, a postulate you could run in a lab. Koch's 1876 anthrax work was so clean it basically dared you to doubt it. The next operating system has to tell a story about broken systems, about host genetics, about the microbiome. No villain. And nobody's written that story in a way institutions can act on. We're just... sitting in the gap.
